NICE advice on asthma steroid choice
The National Institute for Clinical Excellence will be appraising the use of steroids for chronic asthma as part of its 10th wave of appraisals, which should be completed in 2006.
It will look at the clinical and cost-effectiveness of
beclomethasone, budesonide and fluticasone and aims to advise which patients will benefit from which steroid.
Asthma guidance is also due out later this month from the British Thoracic Society and Scottish Intercollegiate Guidelines Network.